Tetanus Diphtheria and Pertussis Vaccine Tdap for Adolescents
- Slides: 23
Tetanus, Diphtheria and Pertussis Vaccine (Tdap) for Adolescents and Adults Trudy V. Murphy, MD March 8, 2006 National Immunization Program Centers for Disease Control and Prevention
Tdap for Adolescents and Adults • Background rationale • Recommendations • Challenges 03 -08 -06
Reported Pertussis Cases U. S. , 1922 -2004 30, 000 300, 000 25, 000 > 18 yrs 20, 000 Number of cases 250, 000 15, 000 11 -18 yrs DTP 10, 000 200, 000 5, 000 < 11 yrs 0 1990 150, 000 1995 2000 100, 000 50, 000 0 1922 1930 03 -08 -06 1940 1950 1960 Year 1970 1980 1990 2000
Adolescent and Adult Pertussis Estimated Annual Number of Cases Age Population Incidence/100, 000 (years) (Millions)* 100 350 11 -18 ~30, 000 ~105, 000 cases 19 -64 ~170, 000 ~600, 000 cases *2000 census Incidence from MA, WI DOH: unpublished data, 03 -08 -06 Ward 2005, Strebel 2001, Nennig 1996
30 10000 20 DTP 10 5000 0 1980 1990 2000 03 -08 -06 Year 20 00 19 90 19 80 19 70 19 60 19 50 19 40 0 19 30 Number of Deaths Reported Pertussis Deaths U. S. , 1922— 2004
Relationship of Reported Source to 494* Infants <4 Months of Age with Pertussis, 1999 -2002 Relationship of source to infant Unknown Mother Father Grandparent Sibling Other Number %* 282 75 29 17 57% 15% 6% 3% 38 53 8% 11% Adapted from Bisgard K et al. Pediatr Infect Dis J 2004 24%
Health-Care Workers with Pertussis Adult-Care Settings Author (year) Location Boulay (2006) Ward, 2005 Zivna (2005)* Bagget (2005)* 03 -08 -06 Index Case 20 Cases Close Contacts Hem-Oncology Care HCW Unit 10 117 General Hospital (France) PACU* HCW 17 74 HCW 3 191 Obstetric Clinic HCW 7 737
Pertussis or “Whooping Cough” Adolescents and Adults • Paroxysmal cough 80% -100% – Lasting median 6 -9 weeks • • Post-tussive vomiting ~50% Whoop ~30% - 60% Disturbed sleep 3/4 Weight loss 1/3 ACIP June & October 2005 03 -08 -06
Morbidity from Pertussis Reported Cases among Adolescents and Adults • • • 03 -08 -06 Incontinence, 28% >18 years Rib fracture, 1%-4% Syncope 3%-6% Pneumonia 2%-5% Hospitalization 1% -3% Lee G. et al CID 2004; 39: 1572 ACIP June & October 2005
Impact of Pertussis among Adolescents and Adults • Medical costs • Missed school (mean 5. 5 days) or work (mean 10 days) • Public health and infection control responses: time, testing, treatment, prophylaxis 03 -08 -06 Lee G. et al CID 2004; 39: 1572 ACIP June & October 2005
Rationale for a Tdap Vaccination Program for Adolescents and Adults • To protect the Tdap recipient from pertussis • To decrease spread of B. pertussis to persons at risk of severe pertussis (e. g. , infants aged <12 months, adults with co-morbid conditions) • To reduce cost and disruption of pertussis in institutional settings • To reduce the reservoir B. pertussis 03 -08 -06
Tetanus Toxoid, Reduced Diphtheria Toxoid and Pertussis Antigens (Tdap) • BOOSTRIX® (GSK) May 3, 2005 – Licensed use: 10 -18 years of age • ADACEL™ (sanofi pasteur) June 10, 2005 – Licensed use: 11 -64 years of age • Single Dose 03 -08 -06
Tdap Background • Safe and immunogenic • Efficacy against pertussis ~85% – Inferred from non-inferiority with responses among infants protected after 3 -doses DTa. P • Protection 5 -10 years; boosters likely to maintain protection • Cost ~ $20 per dose more than Td 03 -08 -06
ACIP Recommends Tdap for Adolescents, June 2005 • http: //www. cdc. gov/mmwr/PDF/rr/rr 5 5 e 223. pdf • Routine: 11 -12 years of age instead of Td • Catch-up for pertussis protection 03 -08 -06 – 11 -18 years of age if >5 years since last Td, DTa. P (DTP, DT) – Interval shorter than 5 years can be used in settings with increased risk for pertussis or its complications
Safety of Short Interval Tdap after Td (or DTP/DTa. P) 3 Canadian Studies • Largest: province-wide, schoolbased, non-randomized, open label, >7000 students – Tdap ~ 2 years (18 -23 months) vs >10 years after last Td – No increase in adverse events 03 -08 -06 Halperin SA. Pediatr Infect Dis J 2006 (in press)
ACIP Recommends* Tdap for Adults October 2005 -February 2006 • Routine: Adults 19 -64 years of age to replace next dose of Td • Short interval since last Td – To protect infants (“Cocoon”) – To protect health-care workers 03 -08 -06 *Provisional until published by MMWR
ACIP Recommends* Tdap for Adults October 2005 • To protect infants (“Cocoon”) – Adults <65 years of age who have or who anticipate having contact with an infant <12 months of age – Women in the immediate postpartum period (if no previous Tdap) – An interval of 2 years or more since last Td is suggested 03 -08 -06 *Provisional until published by MMWR
ACIP Recommends* Tdap for Adults February 2006 • To protect health-care workers – Direct patient contact in hospitals and ambulatory care settings – Interval of 2 years or more since last Td is recommended – Priority Tdap for workers in contact with infants <12 months of age – Facilities should provide the Tdap and maximize uptake 03 -08 -06 *Provisional until published by MMWR
Tdap for Adolescents and Adults Challenges • Educate: physicians, public – Morbidity, mortality from pertussis – Improve coverage among adults • 19 - 64 years of age, Td 55%67% (NHIS 1999) • Laboratory diagnostics • Potential benefits of Tdap for pregnant women and their infant 03 -08 -06
Tdap for Adolescents and Adults Challenges • Post-exposure prophylaxis among exposed, vaccinated persons? • Effectiveness of Tdap strategies over time; monitor post-licensing safety • Burden of pertussis, and high risk groups among older adults 03 -08 -06
Reported Cases of Vaccine. Preventable Diseases, United States Disease Smallpox Diphtheria Pertussis Tetanus Polio (paralytic) Measles Mumps Rubella Congenital Rubella Hib (invasive <5 years) 03 -08 -06 Average Annual No. Cases Pre-vaccine 2004 29, 005 0 21, 053 0 192, 752 580 16, 316 4, 000 162, 344 47, 745 152 20, 000 25, 827 34 0 37 258 10 0 17
Acknowledgements ACIP Pertussis Working Group, John Moran, CDC/NIP/BVPD & the DTP-Hib Team • Katrina • Karen Broder Kretsinger • Kristin Brown • Christina Mijalski • Amanda Cohn • Manisha Patel • Margaret Cortese • Pam Srivastava • Kashif Iqbal • Barbara Slade • Patricia Joyce • Tej Tiwari 03 -08 -06
THANK YOU 03 -08 -06
- Tdap vaccine kroger
- Aise medical term
- Preventive measures of diphtheria
- Diphtheria stain
- Bull neck appearance
- Diphtheria cdc
- Diphtheria
- Infants and children 8th edition
- Infants, children, and adolescents 8th edition
- The adolescent in society guided reading
- Difference between tetanus and tetany
- Fajar tetanua
- Ablett score tetanus
- Muscle twitch
- Tetanus vs summation
- Horst allerdist
- Hondenbeet tetanus
- Incomplete tetanus muscle contraction
- Tetanus vs summation
- Charles bell tetanus
- Risus sardonicus
- Tetanus hondenbeet
- Tetanus
- Osha log posting dates